Gilead Boosts Oncology Pipeline with Tango Collaboration
By Michelle Liu
Pharma Deals Review: Vol 2018 Issue 11 (Table of Contents)
Published: 9 Nov-2018
DOI: 10.3833/pdr.v2018.i11.2369 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
In a bid to bolster its oncology franchise, Gilead Sciences has signed a multi-year collaboration with Tango Therapeutics to discover, develop and commercialise immuno-oncology therapies...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS